James Hand

1.6k total citations
32 papers, 495 citations indexed

About

James Hand is a scholar working on Physiology, Pulmonary and Respiratory Medicine and Immunology and Allergy. According to data from OpenAlex, James Hand has authored 32 papers receiving a total of 495 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Physiology, 12 papers in Pulmonary and Respiratory Medicine and 5 papers in Immunology and Allergy. Recurrent topics in James Hand's work include Asthma and respiratory diseases (19 papers), Respiratory and Cough-Related Research (10 papers) and Allergic Rhinitis and Sensitization (5 papers). James Hand is often cited by papers focused on Asthma and respiratory diseases (19 papers), Respiratory and Cough-Related Research (10 papers) and Allergic Rhinitis and Sensitization (5 papers). James Hand collaborates with scholars based in United States, Canada and United Kingdom. James Hand's co-authors include Carl K. Buckner, J. A. Will, Ruth R. Osborn, David C. Underwood, JOHN H. MUSSER, Joseph Chang, T J Torphy, Bradley J. Undem, Linda Novak and S J Newsholme and has published in prestigious journals such as Journal of Medicinal Chemistry, Journal of Pharmacology and Experimental Therapeutics and European Journal of Pharmacology.

In The Last Decade

James Hand

32 papers receiving 453 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
James Hand United States	12	239	156	117	90	70	32	495
Mark Holbrook United Kingdom	15	85 0.4×	262 1.7×	42 0.4×	58 0.6×	17 0.2×	22	558
I. Florentin France	13	54 0.2×	177 1.1×	33 0.3×	245 2.7×	32 0.5×	63	699
S. C. Flores United States	11	63 0.3×	227 1.5×	90 0.8×	86 1.0×	95 1.4×	12	602
Cláudia Silva Portugal	12	34 0.1×	126 0.8×	46 0.4×	104 1.2×	232 3.3×	24	686
D. Biou France	14	50 0.2×	254 1.6×	32 0.3×	88 1.0×	12 0.2×	44	535
Jane K. McGavin New Zealand	10	45 0.2×	90 0.6×	45 0.4×	14 0.2×	70 1.0×	11	577
C. Nerenberg United States	11	98 0.4×	93 0.6×	99 0.8×	22 0.2×	10 0.1×	19	460
L. А. Alexandrova Russia	12	64 0.3×	325 2.1×	37 0.3×	19 0.2×	117 1.7×	43	583
Hideo Shirafuji Japan	10	166 0.7×	219 1.4×	96 0.8×	83 0.9×	22 0.3×	17	464
Tomohiro Yamamoto Japan	15	31 0.1×	180 1.2×	46 0.4×	23 0.3×	26 0.4×	44	724

Countries citing papers authored by James Hand

Since Specialization

Citations

This map shows the geographic impact of James Hand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Hand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Hand more than expected).

Fields of papers citing papers by James Hand

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James Hand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Hand. The network helps show where James Hand may publish in the future.

Co-authorship network of co-authors of James Hand

This figure shows the co-authorship network connecting the top 25 collaborators of James Hand. A scholar is included among the top collaborators of James Hand based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James Hand. James Hand is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Apea, Vanessa, Amber Haley, James Hand, et al.. (2023). Study protocol: the ILANA study – exploring optimal implementation strategies for long-acting antiretroviral therapy to ensure equity in clinical care and policy for women, racially minoritised people and older people living with HIV in the UK – a qualitative multiphase longitudinal study design. BMJ Open. 13(7). e070666–e070666. 11 indexed citations

Tang, Lihua, et al.. (2016). Exploring the roles of standard rectifying circuits on the performance of a nonlinear piezoelectric energy harvester. Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE. 9799. 97990J–97990J. 2 indexed citations

Dreja, Hanna, E O'Sullivan, Corinna Pade, et al.. (2010). Neutralization activity in a geographically diverse East London cohort of human immunodeficiency virus type 1-infected patients: clade C infection results in a stronger and broader humoral immune response than clade B infection. Journal of General Virology. 91(11). 2794–2803. 14 indexed citations

Moyle, Graeme, James Hand, Sundhiya Mandalia, et al.. (2005). Early virologic failure in HIV-1 infected subjects on didanosine/tenofovir/efavirenz: 12-week results from a randomized trial. AIDS. 19(11). 1183–1188. 51 indexed citations

Portsmouth, Simon, Nesrina Imami, António Pires, et al.. (2004). Treatment of primary HIV‐1 infection with nonnucleoside reverse transcriptase inhibitor‐based therapy is effective and well tolerated. HIV Medicine. 5(1). 26–29. 8 indexed citations

Underwood, David C., Ruth R. Osborn, Linda Novak, et al.. (1993). Inhibition of antigen-induced bronchoconstriction and eosinophil infiltration in the guinea pig by the cyclic AMP-specific phosphodiesterase inhibitor, rolipram.. Journal of Pharmacology and Experimental Therapeutics. 266(1). 306–313. 106 indexed citations

Underwood, David C., Ruth R. Osborn, & James Hand. (1992). Lack of late-phase airway responses in conscious guinea pigs after a variety of antigen challenges. Inflammation Research. 37(3-4). 191–194. 11 indexed citations

MUSSER, JOHN H., Anthony F. Kreft, Reinhold H. W. Bender, et al.. (1990). N-[(Arylmethoxy)phenyl] carboxylic acids, hydroxamic acids, tetrazoles, and sulfonyl carboxamides. Potent orally active leukotriene D4 antagonists of novel structure. Journal of Medicinal Chemistry. 33(1). 240–245. 36 indexed citations

MUSSER, JOHN H., Anthony F. Kreft, Reinhold H. W. Bender, et al.. (1989). N-[(Arylmethoxy)phenyl] and N-[(arylmethoxy)naphthyl] sulfonamides: potent orally active leukotriene d4 antagonists of novel structure. Journal of Medicinal Chemistry. 32(6). 1176–1183. 14 indexed citations

10.

Hand, James, et al.. (1989). Pharmacological characterization using selected antagonists of the leukotriene receptors mediating contraction of guinea-pig trachea. Prostaglandins. 37(2). 181–191. 12 indexed citations

11.

Hand, James, et al.. (1989). Prevention and Reversal of Aerosol LTD4-Induced Changes in Guinea Pig Pulmonary Mechanics by Wy-48252, an Orally Active LTD4/E4 Receptor Antagonist. International Archives of Allergy and Immunology. 89(1). 78–82. 2 indexed citations

12.

Hand, James, et al.. (1989). Wy-48,252 (1,1,1-trifluoro-N-[3-(2-quinolinylmethoxy)phenyl]methane sulfonamide) an orally active leukotriene D4 antagonist: Pharmacological characterization in vitro and in vivo in the guinea pig. Prostaglandins Leukotrienes and Essential Fatty Acids. 37(2). 97–106. 8 indexed citations

13.

Chang, Joseph, JOHN H. MUSSER, & James Hand. (1988). Effect of a Novel Leukotriene D4 Antagonist with 5-Lipoxygenase and Cyclooxygenase Inhibitory Activity, Wy-45,911, on Leukotriene-D4- and Antigen-Induced Bronchoconstriction in the Guinea Pig. International Archives of Allergy and Immunology. 86(1). 48–55. 5 indexed citations

14.

Lappe, Rodney W., et al.. (1988). Bronchoprotective and bronchodilator activity of anaritide (human atrial natriuretic factor [102–126]) infusion in the anesthetized guinea pig. Pulmonary Pharmacology. 1(3). 119–123. 6 indexed citations

15.

Chang, Joseph, Pierre Borgeat, R.P. Schleimer, et al.. (1988). Wy-48,252 (1,1,1-trifluoro-N-[3-(2-quinolinylmethoxy)phenyl]methane sulfonamide), an orally active leukotriene antagonist: effects on arachidonic acid metabolism in various inflammatory cells. European Journal of Pharmacology. 148(1). 131–141. 5 indexed citations

16.

MUSSER, JOHN H., Dennis Kubrak, Reinhold H. W. Bender, et al.. (1987). Phenylephrine derivatives as leukotriene D4 antagonists. Journal of Medicinal Chemistry. 30(11). 2087–2093. 6 indexed citations

17.

Lewis, Alan J., Richard P. Carlson, Jennifer Y. Chang, et al.. (1986). The development of Wy-41,195, an orally effective antiallergic drug in animal models. Inflammation Research. 18(3-4). 306–312. 1 indexed citations

18.

Hand, James, J. A. Will, & Carl K. Buckner. (1982). Pharmacological alteration of antigen-induced contraction of pulmonary arteries isolated from the actively sensitized guinea pig.. Journal of Pharmacology and Experimental Therapeutics. 220(3). 526–535. 9 indexed citations

19.

Hand, James, J. A. Will, & Carl K. Buckner. (1981). Effects of leukotrienes on isolated guinea-pig pulmonary arteries. European Journal of Pharmacology. 76(4). 439–442. 52 indexed citations

20.

Hand, James & Carl K. Buckner. (1979). Effects of selected antagonists on ovalbumin-induced contraction of tracheal strips isolated from the actively sensitized guinea-pig. International Journal of Immunopharmacology. 1(3). 189–195. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact